Stockscreener 앱 받기
2.425
3.39%
-0.085
시간 외 거래:
2.48
0.055
+2.27%
전일 마감가:
$2.51
열려 있는:
$2.57
하루 거래량:
1.31M
Relative Volume:
0.27
시가총액:
$43.00M
수익:
-
순이익/손실:
$-43.27M
주가수익비율:
-1.5747
EPS:
-1.54
순현금흐름:
$-41.11M
1주 성능:
-5.27%
1개월 성능:
+103.78%
6개월 성능:
-50.55%
1년 성능:
-94.09%
1일 변동 폭
$2.33
$2.57
1주일 범위
$2.33
$2.98
52주 변동 폭
$1.0404
$58.20
Biovie Inc Stock (BIVI) Company Profile
명칭
Biovie Inc
전화
775-888-3162
주소
680 W NYE LANE, CARSON CITY
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 개시 | B. Riley Securities | Buy |
Biovie Inc 주식(BIVI)의 최신 뉴스
BioVie's Upcoming Parkinson's Disease Clinical Trial is Fully Funded - The Manila Times
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded - StockTitan
BioVie Raises Capital Through Direct Stock Offering - MSN
BioVie Inc. Announces Closing of Registered Direct Offering - GlobeNewswire
BioVie Raises $3.24 Million in Direct Offering - TipRanks
BioVie sets price for $3.2 million stock offering By Investing.com - Investing.com Australia
BioVie prices stock offering at $2.83 per share By Investing.com - Investing.com Canada
BIVIBioVie, Inc. Latest Stock News & Market Updates - StockTitan
BioVie prices stock offering at $2.83 per share - Investing.com
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
BioVie sets price for $3.2 million stock offering - Investing.com India
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
Short Interest in BioVie Inc. (NASDAQ:BIVI) Decreases By 51.0% - MarketBeat
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Carson City, Nevada, October 23, 2024 — BioVie Inc. (NASDAQ: BIVI), a clinical-stage company focused on developing innovative drug therapies for ch - Defense World
BioVie Raises $6 Million in Strategic Funding - TipRanks
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - StockTitan
BioVie Announces $6 Million Stock Offering and Placement - TipRanks
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioVie announces $6 million stock offering and warrants By Investing.com - Investing.com Australia
BioVie announces $6 million stock offering and warrants - Investing.com India
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
BioVie 2.667M share registered direct offering priced at $2.25 - TipRanks
BioVie Inc. Announces Pricing of Registered Direct Offering - GlobeNewswire
BioVie stock dips after pricing offering to raise $6.66M - MSN
BioVie Announces Stock Offering and Private Placement - Yahoo Finance
Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - The Manila Times
Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - GlobeNewswire
BioVie announces $6.7 million direct stock offering - Investing.com India
BioVie Secures $6.66 Million Through Direct Offering - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
3 Penny Stocks to Watch Now, 10/22/24 - TipRanks
BioVie stock dips after pricing offering to raise $6.66M (NASDAQ:BIVI) - Seeking Alpha
BioVie announces $6.7 million direct stock offering By Investing.com - Investing.com Australia
BioVie 4.443M share registered direct offering priced at $1.50 - TipRanks
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
BioVie Sees Unusually Large Options Volume (NASDAQ:BIVI) - MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
BioVie (BIVI) Stock Surges After Hours On A Patent Milestone - Stocks Telegraph
BIVI Stock Quote Price and Forecast - CNN
BioVie secures patent for terlipressin formulation - Investing.com India
BioVie secures patent for terlipressin formulation By Investing.com - Investing.com UK
BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin - GlobeNewswire
Biovie Inc (BIVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Biovie Inc 주식 (BIVI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DO CUONG V | President & CEO |
Nov 30 '23 |
Buy |
1.78 |
10,000 |
17,800 |
68,759 |
2.02%
0.47%
자본화:
|
볼륨(24시간):